Core Viewpoint - Zhang Yushuang, at 38 years old, officially takes over as the sole actual controller of Dongyangguang Group, a private enterprise with total assets exceeding 80 billion yuan, marking a significant transition in leadership and strategy for the company [2][3][5]. Group 1: Leadership Transition - On December 29, 2025, an announcement was made that Guo Meilan transferred all her indirectly held shares in Dongyangguang to Zhang Yushuang, making him the sole actual controller of the company [2][3]. - Prior to the transfer, Zhang Yushuang and Guo Meilan held significant stakes in subsidiaries that controlled 38.70% of Dongyangguang's shares [4]. - This transfer signifies a complete handover of the family business to Zhang Yushuang, as Guo Meilan steps back due to age [7]. Group 2: Company Background - Dongyangguang Group was founded in 1997 by Zhang Zhongneng and Guo Meilan, starting with aluminum foil processing and has since grown into a top 500 private enterprise in China with assets over 80 billion yuan [2][9]. - The company has diversified into three main sectors: electronic new materials, biomedicine, and health care, with two listed companies under its umbrella [2][10]. Group 3: Zhang Yushuang's Experience and Strategy - Zhang Yushuang has 15 years of experience within the company, having started in the research department and gradually moving up to leadership roles [5][6]. - Since taking over, he has initiated a "second entrepreneurship" phase, focusing on transforming the company from traditional manufacturing to intelligent manufacturing, including a significant investment of 28 billion yuan into the IDC sector and advancements in AI and robotics [2][13][16]. - Zhang aims to achieve a target of 50% of products exported, 50% of technology being original, and 50% of revenue coming from high-margin new products by 2030, with a planned R&D investment of 6 billion yuan over the next three years [14][15]. Group 4: Financial Performance and Market Position - As of the end of 2025, the combined market value of Dongyangguang and Dongyangguang Pharmaceutical is approximately 90.6 billion yuan [5]. - The company has shown significant financial improvement, with a net profit of 375 million yuan in 2024, a 227.41% increase year-on-year, and a record net profit of 906 million yuan in the first three quarters of 2025 [16].